Literature DB >> 28542831

Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.

Massimo Andreatta1, Vanessa I Jurtz2, Thomas Kaever3, Alessandro Sette3, Bjoern Peters3, Morten Nielsen1,2.   

Abstract

MHC class II molecules play a fundamental role in the cellular immune system: they load short peptide fragments derived from extracellular proteins and present them on the cell surface. It is currently thought that the peptide binds lying more or less flat in the MHC groove, with a fixed distance of nine amino acids between the first and last residue in contact with the MHCII. While confirming that the great majority of peptides bind to the MHC using this canonical mode, we report evidence for an alternative, less common mode of interaction. A fraction of observed ligands were shown to have an unconventional spacing of the anchor residues that directly interact with the MHC, which could only be accommodated to the canonical MHC motif either by imposing a more stretched out peptide backbone (an 8mer core) or by the peptide bulging out of the MHC groove (a 10mer core). We estimated that on average 2% of peptides bind with a core deletion, and 0·45% with a core insertion, but the frequency of such non-canonical cores was as high as 10% for certain MHCII molecules. A mutational analysis and experimental validation of a number of these anomalous ligands demonstrated that they could only fit to their MHC binding motif with a non-canonical binding core of length different from nine. This previously undescribed mode of peptide binding to MHCII molecules gives a more complete picture of peptide presentation by MHCII and allows us to model more accurately this event.
© 2017 John Wiley & Sons Ltd.

Keywords:  MHC class II; deletions; insertions; machine learning; non-canonical binding

Mesh:

Substances:

Year:  2017        PMID: 28542831      PMCID: PMC5588850          DOI: 10.1111/imm.12763

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Amino acid substitution matrices from protein blocks.

Authors:  S Henikoff; J G Henikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

2.  Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Authors:  Soumya G Remesh; Massimo Andreatta; Ge Ying; Thomas Kaever; Morten Nielsen; Curtis McMurtrey; William Hildebrand; Bjoern Peters; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

3.  Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach.

Authors:  Massimo Andreatta; Ole Lund; Morten Nielsen
Journal:  Bioinformatics       Date:  2012-10-24       Impact factor: 6.937

4.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

5.  MHC binding prediction with KernelRLSpan and its variations.

Authors:  Wen-Jun Shen; Yu Ting Wei; Xin Guo; Stephen Smale; Hau-San Wong; Shuai Cheng Li
Journal:  J Immunol Methods       Date:  2014-03-03       Impact factor: 2.303

6.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.

Authors:  Jason Greenbaum; John Sidney; Jolan Chung; Christian Brander; Bjoern Peters; Alessandro Sette
Journal:  Immunogenetics       Date:  2011-02-09       Impact factor: 2.846

7.  Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund
Journal:  BMC Bioinformatics       Date:  2007-07-04       Impact factor: 3.169

8.  The immune epitope database (IEDB) 3.0.

Authors:  Randi Vita; James A Overton; Jason A Greenbaum; Julia Ponomarenko; Jason D Clark; Jason R Cantrell; Daniel K Wheeler; Joseph L Gabbard; Deborah Hix; Alessandro Sette; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

9.  Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity.

Authors:  Geert P M Mommen; Fabio Marino; Hugo D Meiring; Martien C M Poelen; Jacqueline A M van Gaans-van den Brink; Shabaz Mohammed; Albert J R Heck; Cécile A C M van Els
Journal:  Mol Cell Proteomics       Date:  2016-01-13       Impact factor: 5.911

10.  Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove.

Authors:  Curtis McMurtrey; Thomas Trolle; Tiffany Sansom; Soumya G Remesh; Thomas Kaever; Wilfried Bardet; Kenneth Jackson; Rima McLeod; Alessandro Sette; Morten Nielsen; Dirk M Zajonc; Ira J Blader; Bjoern Peters; William Hildebrand
Journal:  Elife       Date:  2016-01-29       Impact factor: 8.140

View more
  7 in total

Review 1.  Computational Tools for the Identification and Interpretation of Sequence Motifs in Immunopeptidomes.

Authors:  Bruno Alvarez; Carolina Barra; Morten Nielsen; Massimo Andreatta
Journal:  Proteomics       Date:  2018-02-26       Impact factor: 3.984

2.  New tools for MHC research from machine learning and predictive algorithms to the tumour immunopeptidome.

Authors:  Daniel M Altmann
Journal:  Immunology       Date:  2018-07       Impact factor: 7.397

Review 3.  Alternative tumour-specific antigens.

Authors:  Christof C Smith; Sara R Selitsky; Shengjie Chai; Paul M Armistead; Benjamin G Vincent; Jonathan S Serody
Journal:  Nat Rev Cancer       Date:  2019-07-05       Impact factor: 60.716

Review 4.  Predicting Antigen Presentation-What Could We Learn From a Million Peptides?

Authors:  David Gfeller; Michal Bassani-Sternberg
Journal:  Front Immunol       Date:  2018-07-25       Impact factor: 7.561

5.  Challenges targeting cancer neoantigens in 2021: a systematic literature review.

Authors:  Ina Chen; Michael Y Chen; S Peter Goedegebuure; William E Gillanders
Journal:  Expert Rev Vaccines       Date:  2021-06-09       Impact factor: 5.683

6.  Footprints of antigen processing boost MHC class II natural ligand predictions.

Authors:  Carolina Barra; Bruno Alvarez; Sinu Paul; Alessandro Sette; Bjoern Peters; Massimo Andreatta; Søren Buus; Morten Nielsen
Journal:  Genome Med       Date:  2018-11-16       Impact factor: 11.117

Review 7.  Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors.

Authors:  Anja Mösch; Silke Raffegerst; Manon Weis; Dolores J Schendel; Dmitrij Frishman
Journal:  Front Genet       Date:  2019-11-19       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.